Mercer Capital Advisers’s AbbVie ABBV Stock Holding History

Mercer Capital Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300	Closed	-$34K	–	150
2021 Q2	$34K	Hold	300	–	–	0.02%	159
2021 Q1	$33K	Hold	300	–	–	0.02%	157
2020 Q4	$32K	Hold	300	–	–	0.02%	152
2020 Q3	$26K	Hold	300	–	–	0.02%	157
2020 Q2	$29K	Hold	300	–	–	0.02%	153
2020 Q1	$23K	Hold	300	–	–	0.02%	155
2019 Q4	$27K	Hold	300	–	–	0.02%	163
2019 Q3	$23K	Hold	300	–	–	0.01%	167
2019 Q2	$22K	Hold	300	–	–	0.01%	171
2019 Q1	$24K	Hold	300	–	–	0.02%	168
2018 Q4	$28K	Sell	300 -49	-14%	-$4.31K	0.02%	162
2018 Q3	$33K	Hold	349	–	–	0.02%	162
2018 Q2	$32K	Hold	349	–	–	0.02%	165
2018 Q1	$33K	Hold	349	–	–	0.02%	164
2017 Q4	$34K	Hold	349	–	–	0.02%	166
2017 Q3	$31K	Hold	349	–	–	0.02%	179
2017 Q2	$25K	Hold	349	–	–	0.02%	190
2017 Q1	$23K	Hold	349	–	–	0.02%	195
2016 Q4	$22K	Hold	349	–	–	0.02%	196
2016 Q3	$22K	Hold	349	–	–	0.02%	206
2016 Q2	$22K	Hold	349	–	–	0.02%	204
2016 Q1	$20K	Hold	349	–	–	0.02%	204
2015 Q4	$21K	Hold	349	–	–	0.02%	210
2015 Q3	$19K	Hold	349	–	–	0.02%	209
2015 Q2	$23K	Hold	349	–	–	0.02%	210
2015 Q1	$20K	Hold	349	–	–	0.02%	216
2014 Q4	$22K	Buy	+349	New	+$22K	0.02%	211

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mercer Capital Advisers's ABBV Position: Q3 2021 in Review

Mercer Capital Advisers sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 300 shares — an estimated $34K sold.

Mercer Capital Advisers first reported a position in ABBV in Q4 2014 and held it in 27 quarters. The position peaked at $34K in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Mercer Capital Advisers reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Mercer Capital Advisers sold 300 AbbVie shares in Q3 2021, an estimated $34K.
Mercer Capital Advisers first reported a position in AbbVie in Q4 2014 and held it in 27 quarters.
Mercer Capital Advisers's AbbVie position peaked at $34K in Q2 2021.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Mercer Capital Advisers's 13F filing for Q3 2021, filed 27 Oct 2021.